|
Pharmacology
Citations 91-100 of 165 total displayed.
|
Past content
(since Dec 2002):
|
- BASIC SCIENCE
Variation of immunological response in methotrexate-induced pneumonitis
- B. Chikura, N. Sathi, S. Lane, and J. K. Dawson
Rheumatology 2008; 47: 1647-1650.
[Abstract]
[Full Text]
- CLINICAL
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy
- I. Olivieri, S. de Portu, C. Salvarani, A. Cauli, E. Lubrano, A. Spadaro, F. Cantini, M. S. Cutro, A. Mathieu, M. Matucci-Cerinic, N. Pappone, L. Punzi, R. Scarpa, L. G. Mantovani, and for the PACE working group
Rheumatology 2008; 47: 1664-1670.
[Abstract]
[Full Text]
- CLINICAL
Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis
- C.-C. Szeto, B. C.-H. Kwan, F. M.-M. Lai, L.-S. Tam, E. K.-M. Li, K.-M. Chow, W. Gang, and P. K.-T. Li
Rheumatology 2008; 47: 1678-1681.
[Abstract]
[Full Text]
- CLINICAL
Eligibility of rheumatoid arthritis patients for anti-TNF- therapy according to the 2005 recommendations of the French and British Societies for Rheumatology
- B. Fautrel, R. M. Flipo, and A. Saraux
Rheumatology 2008; 47: 1698-1703.
[Abstract]
[Full Text]
- LETTERS TO THE EDITOR
Switching anti-TNF therapy in ankylosing spondylitis
- D. J. Pradeep, A. C. Keat, K. Gaffney, A. Brooksby, J. Leeder, and C. Harris
Rheumatology 2008; 47: 1726-1727.
[Extract]
[Full Text]
- CASE REPORTS
The use of rituximab to treat a patient with ankylosing spondylitis and hepatitis B
- C. Rodríguez-Escalera and A. Fernández-Nebro
Rheumatology 2008; 47: 1732-1733.
[Extract]
[Full Text]
- CASE REPORTS
Paraneoplastic scleroderma secondary to hairy cell leukaemia successfully treated with cladribine
- M. Juarez, R. Marshall, C. Denton, and R. Evely
Rheumatology 2008; 47: 1734-1735.
[Extract]
[Full Text]
- EDITORIALS
The British Society for Rheumatology Biologics Register: 6 years on
- K. L. Hyrich, K. D. Watson, D. A. Isenberg, and D. P. M. Symmons on behalf of the BSR Biologics Register
Rheumatology 2008; 47: 1441-1443.
[Extract]
[Full Text]
- BASIC SCIENCE
The value of synovial cytokine expression in predicting the clinical response to TNF antagonist therapy (infliximab)
- M. H. Buch, R. J. Reece, M. A. Quinn, A. English, G. Cunnane, K. Henshaw, S. J. Bingham, V. Bejarano, J. Isaacs, and P. Emery
Rheumatology 2008; 47: 1469-1475.
[Abstract]
[Full Text]
- CLINICAL
Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis
- G. Simonini, M. E. Zannin, R. Caputo, F. Falcini, M. de Martino, F. Zulian, and R. Cimaz
Rheumatology 2008; 47: 1510-1514.
[Abstract]
[Full Text]
|
|
